E2 ModerateModerate confidencePEM unclearCase-ControlPeer-reviewedMachine draft
Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort.
van Kuppeveld, Frank J M, de Jong, Arjan S, Lanke, Kjerstin H et al. · BMJ (Clinical research ed.) · 2010 · DOI
Quick Summary
Researchers in the Netherlands tested whether a virus called XMRV, which had been reported in ME/CFS patients in other studies, was present in blood samples from Dutch ME/CFS patients. Using sensitive laboratory tests, they found no trace of this virus in any of the patients or healthy control participants. This challenges earlier claims that XMRV might be connected to ME/CFS.
Why It Matters
This independent replication study from a European cohort was crucial for evaluating whether XMRV—initially reported as a potential ME/CFS biomarker—could be confirmed in different populations. Negative findings from well-controlled studies help redirect research efforts toward more promising biological hypotheses and prevent patients from pursuing unproven treatments based on unverified viral claims.
Observed Findings
- No XMRV sequences detected in any of the 32 ME/CFS patients using real-time PCR assays
- No XMRV sequences detected in any of the 43 matched control participants using nested PCR assays
- Spiking experiments confirmed assay sensitivity of ≥10 XMRV copies per 10⁵ peripheral blood mononuclear cells
- Positive and negative controls functioned as expected, validating assay reliability
Inferred Conclusions
- XMRV is not present in peripheral blood mononuclear cells of Dutch ME/CFS patients
- The association between XMRV and ME/CFS reported in prior studies cannot be confirmed in this independent European cohort
- Claims that XMRV is associated with ME/CFS in the majority of patients are unsupported by this evidence
Remaining Questions
- Why do some studies report XMRV detection in ME/CFS patients while others, like this one, do not? Could differences in patient populations, sample processing, or PCR methodologies account for discrepant findings?
- Was XMRV ever genuinely present in some ME/CFS patients, or were earlier positive results due to contamination or methodological error?
- If XMRV is not a primary pathogenic factor in ME/CFS, what other viral or non-viral agents might contribute to disease mechanisms?
What This Study Does Not Prove
This study does not prove that no virus is involved in ME/CFS pathogenesis, only that XMRV specifically was not detected in this Dutch cohort. It does not rule out other potential viral triggers or cofactors in ME/CFS. The study also cannot determine whether XMRV absence reflects true non-association or differences in viral persistence, tissue tropism, or detection timing across populations.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionSmall Sample
Metadata
- DOI
- 10.1136/bmj.c1018
- PMID
- 20185493
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →